BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22225527)

  • 1. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
    Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
    BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
    Corso G; Comelli G; Veronesi P; Bianchi B; Petitto S; Polizzi A; Girardi A; Cioffi A; La Vecchia C; Bagnardi V; Magnoni F
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16147-16155. PubMed ID: 37639007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients.
    Corso G; Trovato CM; Petitto S; Girardi A; De Scalzi AM; Bianchi B; Magnoni F; Cioffi A; Galimberti V; Veronesi P; Mazzarol G; Maisonneuve P
    Oncology; 2024; 102(4):374-379. PubMed ID: 37725907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
    Corso G; Davis JL; Strong VE
    J Surg Oncol; 2024 May; 129(6):1082-1088. PubMed ID: 38389278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS.
    Tabassum S; Munir F; Al Awadh AA; Anwar Z
    Exp Oncol; 2023 Oct; 45(2):170-179. PubMed ID: 37824775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells.
    Beetham H; Chen A; Telford BJ; Single A; Jarman KE; Lackovic K; Luxenburger A; Guilford P
    Sci Rep; 2019 Aug; 9(1):12511. PubMed ID: 31467357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
    Stillman MD; Kusche N; Toledano S; Hilfrank KJ; Yoon C; Gabre JT; Rustgi SD; Hur C; Kastrinos F; Ryeom SW; Yoon SS
    J Surg Oncol; 2022 Dec; 126(8):1413-1422. PubMed ID: 36063148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.
    Corso G; Montagna G; Figueiredo J; La Vecchia C; Fumagalli Romario U; Fernandes MS; Seixas S; Roviello F; Trovato C; Guerini-Rocco E; Fusco N; Pravettoni G; Petrocchi S; Rotili A; Massari G; Magnoni F; De Lorenzi F; Bottoni M; Galimberti V; Sanches JM; Calvello M; Seruca R; Bonanni B
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.
    Förster A; Brand F; Banan R; Hüneburg R; Weber CAM; Ewert W; Kronenberg J; Previti C; Elyan N; Beyer U; Martens H; Hong B; Bräsen JH; Erbersdobler A; Krauss JK; Stangel M; Samii A; Wolf S; Preller M; Aretz S; Wiese B; Hartmann C; Weber RG
    Acta Neuropathol; 2021 Jul; 142(1):191-210. PubMed ID: 33929593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline
    Wang SC; Yeu Y; Hammer STG; Xiao S; Zhu M; Hong C; Clemenceau JR; Yoon LY; Nassour I; Shen J; Agarwal D; Reznik SI; Mansour JC; Yopp AC; Zhu H; Hwang TH; Porembka MR
    Cancer Res; 2020 Jun; 80(11):2114-2124. PubMed ID: 32269045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk individuals' perceptions of reproductive genetic testing for CDH1 mutations.
    Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
    Fam Cancer; 2017 Oct; 16(4):531-535. PubMed ID: 28204904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Metastatic
    Caggiari L; Miolo G; Buonadonna A; Basile D; Santeufemia DA; Cossu A; Palmieri G; De Zorzi M; Fornasarig M; Alessandrini L; Canzonieri V; Lo Re G; Puglisi F; Steffan A; Cannizzaro R; De Re V
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profile analysis of diffuse-type gastric cancers.
    Lee YS; Cho YS; Lee GK; Lee S; Kim YW; Jho S; Kim HM; Hong SH; Hwang JA; Kim SY; Hong D; Choi IJ; Kim BC; Kim BC; Kim CH; Choi H; Kim Y; Kim KW; Kong G; Kim HL; Bhak J; Lee SH; Lee JS
    Genome Biol; 2014 Apr; 15(4):R55. PubMed ID: 24690483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trends, challenges, and reflections on early-onset gastric cancer].
    Wang XF; Sun YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):425-429. PubMed ID: 38778679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast Cancer.
    Giunta EF; Arrichiello G; Pappalardo A; Federico P; Petrillo A
    Cancer Treat Res; 2023; 188():89-104. PubMed ID: 38175343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of pathogenic germline variants in gastric cancer and development of "GasCanBase" database.
    Hossain MU; Ahammad I; Moniruzzaman M; Akter Lubna M; Bhattacharjee A; Mahmud Chowdhury Z; Ahmed I; Hosen MB; Biswas S; Chandra Das K; Keya CA; Salimullah M
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1906. PubMed ID: 37867380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic Mutational Landscape in Mexican Patients:
    Cerrato-Izaguirre D; Chirino YI; Prada D; Quezada-Maldonado EM; Herrera LA; Hernández-Guerrero A; Alonso-Larraga JO; Herrera-Goepfert R; Oñate-Ocaña LF; Cantú-de-León D; Meneses-García A; Basurto-Lozada P; Robles-Espinoza CD; Camacho J; García-Cuellar CM; Sánchez-Pérez Y
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming.
    Zou G; Huang Y; Zhang S; Ko KP; Kim B; Zhang J; Venkatesan V; Pizzi MP; Fan Y; Jun S; Niu N; Wang H; Song S; Ajani JA; Park JI
    J Exp Med; 2024 Apr; 221(4):. PubMed ID: 38411616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.
    Herrera-Pariente C; Bonjoch L; Muñoz J; Fernàndez G; Soares de Lima Y; Mahmood R; Cuatrecasas M; Ocaña T; Lopez-Prades S; Llargués-Sistac G; Domínguez-Rovira X; Llach J; Luzko I; Díaz-Gay M; Lazaro C; Brunet J; Castillo-Manzano C; García-González MA; Lanas A; Carrillo M; Hernández San Gil R; Quintero E; Sala N; Llort G; Aguilera L; Carot L; Diez-Redondo P; Jover R; Ramon Y Cajal T; Cubiella J; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
    Gastric Cancer; 2024 May; ():. PubMed ID: 38796558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer.
    Han X; Jia X; Sheng C; Li M; Han J; Duan F; Wang K
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102287. PubMed ID: 38253255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.